Isolation of novel high-osmolarity resistant cho dg44 cells after suspension of dna mismatch re

BioProcess International

Volumn 8, Issue 4, 2010, Pages 68-76

  Liu, Xiaoguang ^a   Liu, Jian ^a   Wright, Tasha Williams ^a   Lee, Jessica ^a   Lio, Peggy ^a   Donahue Hjelle, Laurel ^a   Ravnikar, Paula ^a   Wu, Florence ^a  

^a Life Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL ISOLATION; CELL LINE; CELL POPULATION; CELL STRUCTURE; GENE DISRUPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HAMSTER; HOST CELL; MISMATCH REPAIR; NONHUMAN; OSMOLARITY; PROTEIN EXPRESSION;

EID: 77953440301     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (25)

1. Wurm FM. Production of Recombinant Protein Therapeutics in Cultivated Mammalian Cells. Nat. Biotechnol. 22(11) 2004: 1393-1398. (Pubitemid 39482858)
2. Ozturk SS, Palsson BO. Effect of Medium Osmolarity on Hybridoma Growth, Metabolism, and Antibody Production. Biotechnol. Bioeng. 37(10) 1991: 989-993
3. 2 and Osmolarity: Intracellular pH, Cell Size, Apoptosis, and Metabolism. Biotechnol. Bioeng. 77(4) 2002: 369-380.
4. Reddy S, Miller WM. Effects of Abrupt and Gradual Osmotic Stress on Antibody Production and Content in Hybridoma Cells That Differ in Production Kinetics. Biotechnol. Prog. 10(2) 1994: 165-173. (Pubitemid 2069690)
5. Sun Z, et al. Hyperosmotic Stress in Murine Hybridoma Cells: Effects on Antibody Transcription, Translation, Posttranslational Processing and the Cell Cycle. Biotechnol. Prog. 20(2) 2004: 576-589. (Pubitemid 38459165)
6. Shen D, Sharfstein ST. Genome-Wide Analysis of the Transcriptional Response of Murine Hybridomas to Osmotic Shock. Biotechnol. Bioeng. 93(1) 2005: 132-145. (Pubitemid 43117066)
7. Yee JC, et al. Genomic and Proteomic Exploration of CHO and Hybridoma Cells under Sodium Butyrate Treatment. Biotechnol. Bioeng. 99(5) 2008: 1186-1204.
8. Kim MS, et al. Biphasic Culture Strategy Based on Hyperosmotic Pressure for Improved Humanized Antibody Production in Chinese Hamster Ovary Cell Culture. In Vitro Cell Dev. Biol.\Animal 38(6) 2002: 314-319.
9. Wu MH, et al. The Effect of Hyperosmotic Pressure on Antibody Production and Gene Expression in the GS-NS0 Cell Line. Biotechnol. Appl. Biochem. 40(1) 2004: 41-46.
10. Paul Jr WC, et al. Maintaining Product Titer While Replacing Undefined Components in a CHO Culture System. BioProcess Int. 7(8) 2009: 30-38.
11. Zhang J, Robinson D. Development of Animal-Free, Protein-Free and Chemically Defined Media for NS0 Cell Culture. Cytotechnol. 48, June 2005: 59-74. (Pubitemid 41752626)
12. Berdichevsky M, et al. Establishment of Higher Passage PER.C6 Cells for Adenovirus Manufacture. Biotechnol. Prog. 24(1) 2008: 158-165. (Pubitemid 351231262)
13. Arden N, Nivtchanyong T, Betenbaugh MJ. Cell Engineering Blocks Stress and Improve Biotherapeutic Production. Bioprocessing J. 3(1) 2004: 23-28.
14. Minch SL, Kallio PT, Bailey JE. Tissue Plasminogen Activator Coexpressed in Chinese Hamster Ovary Cells with Alpha (2,6)-Sialytransferase Contains NeuAc Alpha (2,6) Gal Beta (1,4) Glc-N-AcR Linkages. Biotechnol. Prog. 11(3) 1995: 348-351.
15. Shinkawa T, et al. The Absence of Fucose But Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-Type Oligosaccharides Shows the Critical Human IgG1 Complex-Type Oligosaccharides Shows the Critical Role of Enhancing Antibody-Dependent Cellular Cytotoxicity. J. Biol. Chem. 278(5) 2003: 3466-3473. (Pubitemid 36801263)
16. Nicolaides NC, et al. Morphogenics As a Tool for Target Discovery and Drug Development. Ann. NY Acad. of Sci. (Tumor Progression and Therapeutic Resistance supplement) 1059, 2005: 86-96. (Pubitemid 43211614)
17. Parsons R, et al. Mismatch Repair Deficiency in Phenotypically Normal Human Cells. Science 268(5211) 1995: 738-740.
18. Francia G, et al. Gene Expression Analysis of Tumor Spheroids Reveals a Role for Suppressed DNA Mismatch Repair in Multicellular Resistance to Alkylating Agents. Mol. Cell. Biol. 24(15) 2004: 6837-6849. (Pubitemid 38944361)
19. Zegerman P, Diffley JFX. DNA Replication As a Target of the DNA Damage Checkpoint. DNA Repair 8(9) 2009: 1077-1088.
20. Grasso L, et al. Enhancing Therapeutic Antibodies and Titer Yields of Mammalian Cell Lines. BioProcess Int. 2(10) 2004: 58-65.
21. Kline JB, et al. Improving Protein and Antibody Yields in Scalable Mammalian-Cell-Based Manufacturing. BioProcess Int. 4(5) 2006: 42-47.
22. Wagner ED, et al. Evaluation of EMS-Induced DNA Damage in the Single Cell Gel Electrophoresis (Comet) Assay and with Flow Cytometric Analysis of Micronuclei. Teratog. Carcinog. Mutagen. 23(2) 2003: 1-11.
23. Wlaschin KF, Seth G, Hu WS. Toward Genomic Cell Culture Engineering. Cytotechnol. 50 (July) 2006: 121-140. (Pubitemid 44243937)
24. Barnes LM, Dickson AJ. Mammalian Cell Factories for Efficient and Stable Protein Expression. Curr. Opin. Biotechnol. 17(4) 2006: 381-386.
25. Sellick CA, et al. Effective Quenching Processes for Physiologically Valid Metabolite Profiling of Suspension Cultured Mammalian Cells. Anal. Chem. 81(1) 2009: 174-183.